Improving Treatment of Patients With Atrial Fibrillation: Eliminating the Middleman
- PMID: 38939637
- PMCID: PMC11198169
- DOI: 10.1016/j.jacadv.2024.100902
Improving Treatment of Patients With Atrial Fibrillation: Eliminating the Middleman
Keywords: anticoagulation; atrial fibrillation; catheter ablation; sinus rhythm; stroke.
Conflict of interest statement
Dr Prystowsky has served as a consultant for Medtronic and Philips. Dr Padanilam has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
- doi: 10.1016/j.jacadv.2024.100905
References
-
- Colilla S., Crow A., Petkun W., et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142–1147. - PubMed
-
- Prystowsky E.P., Padanilam B.J., Fogel R.F. Treatment of atrial fibrillation. JAMA. 2015;314(3):278–288. - PubMed
-
- Prystowsky E.N. Rate versus rhythm control for atrial fibrillation: has the debate been settled? Circulation. 2022;146:1561–1563. - PubMed
-
- Kirchhof P., Camm A.J., Goette A., et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383:1305–1316. - PubMed
Publication types
LinkOut - more resources
Full Text Sources